Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
GREATBATCH, INC.
SIC 3845 · Electromedical & Electrotherapeutic Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
GREATBATCH, INC.
SIC 3845 · Electromedical & Electrotherapeutic Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
GREATBATCH, INC.
SIC 3845 · Electromedical & Electrotherapeutic Apparatus
Notes
Support
about
terms
$
ITGR
GREATBATCH, INC.
CIK:
0001114483
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
6 Months Ended
Jul. 03, 2026
Jun. 27, 2025
Jul. 03, 2026
Jun. 27, 2025
Income Statement [Abstract]
Sales
$ 464,110
$ 476,494
$ 903,690
$ 913,886
Cost of sales
351,168
347,342
681,153
664,416
Gross profit
112,942
129,152
222,537
249,470
Operating expenses:
Selling, general and administrative
57,699
52,923
116,410
104,083
Research, development and engineering
11,278
14,240
27,521
28,441
Restructuring and other charges
9,437
2,651
12,209
8,056
Total operating expenses
78,414
69,814
156,140
140,580
Operating income
34,528
59,338
66,397
108,890
Interest expense
10,135
9,754
19,869
24,559
(Gain) loss on equity investments
(42)
8
1,426
(173)
Other loss, net (see Note 6)
1,144
3,980
1,460
51,907
Income from continuing operations before taxes
23,291
45,596
43,642
32,597
Provision (benefit) for income taxes
(314)
8,587
3,531
18,053
Income from continuing operations
23,605
37,009
40,111
14,544
Loss from discontinued operations, net of tax
0
0
0
(22)
Net income
$ 23,605
$ 37,009
$ 40,111
$ 14,522
Basic earnings per share:
Income from continuing operations (in dollars per share)
$ 0.69
$ 1.06
$ 1.17
$ 0.42
Loss from discontinued operations (in dollars per share)
0
0
0
0
Basic earnings per share (in dollars per share)
0.69
1.06
1.17
0.42
Diluted earnings per share:
Income from continuing operations (in dollars per share)
0.69
1.04
1.17
0.41
Loss from discontinued operations (in dollars per share)
0
0
0
0
Diluted earnings per share (in dollars per share)
$ 0.69
$ 1.04
$ 1.17
$ 0.41
Weighted average shares outstanding:
Basic (in shares)
34,010
35,035
34,146
34,488
Diluted (in shares)
34,145
35,713
34,290
35,830
Comprehensive Income
Net income
$ 23,605
$ 37,009
$ 40,111
$ 14,522
Other comprehensive income (loss):
Foreign currency translation gain (loss)
(5,576)
47,356
(16,230)
67,647
Change in fair value of cash flow hedges, net of tax
(344)
5,748
(3,235)
10,246
Other comprehensive income (loss)
(5,920)
53,104
(19,465)
77,893
Comprehensive income
$ 17,685
$ 90,113
$ 20,646
$ 92,415
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jul. 03, 2026
Jun. 27, 2025
Cash flows from operating activities:
Net income
$ 40,111
$ 14,522
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
69,549
62,118
Debt related charges included in interest expense
3,263
3,627
Debt conversion inducement expense
0
46,681
Stock-based compensation
12,045
12,536
Non-cash fixed asset impairment
5,893
0
Non-cash lease expense
4,876
5,000
Non-cash (gains) losses on equity investments
1,426
(173)
Contingent consideration fair value adjustment
(1,179)
(309)
Other non-cash losses
2,077
3,143
Deferred income taxes
18
3,942
Gain on sale of discontinued operations
0
(46)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
7,959
(41,014)
Inventories
(36,751)
(14,509)
Prepaid expenses and other assets
(2,247)
71
Contract assets
(6,762)
1,800
Accounts payable
5,591
11,561
Accrued expenses and other liabilities
(11,761)
(23,312)
Income taxes
(9,678)
(10,500)
Net cash provided by operating activities
84,430
75,138
Cash flows from investing activities:
Acquisition of property, plant and equipment
(46,651)
(44,219)
Purchase of equity and other investments, net of distributions
(14,043)
0
Acquisitions, net of cash acquired
0
(170,872)
Other investing activities
108
97
Net cash used in investing activities
(60,586)
(214,994)
Cash flows from financing activities:
Principal payments of long-term debt
0
(657,693)
Proceeds from issuance of convertible notes, net of discount
0
977,500
Proceeds from revolving credit facility
207,600
257,000
Payments of revolving credit facility
(157,600)
(373,000)
Purchase of capped calls
0
(71,000)
Payment of debt issuance costs
(38)
(1,266)
Repurchases of common stock
(50,000)
0
Proceeds from the exercise of stock options
0
3,644
Tax withholdings related to net share settlements of restricted stock unit awards
(10,299)
(16,707)
Principal payments on finance leases
(4,256)
(2,596)
Other financing activities
(5,162)
107
Net cash provided by (used in) financing activities
(19,755)
115,989
Effect of foreign currency exchange rates on cash and cash equivalents
125
459
Net increase (decrease) in cash and cash equivalents
4,214
(23,408)
Cash and cash equivalents, beginning of period
17,161
46,543
Cash and cash equivalents, end of period
$ 21,375
$ 23,135
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Jul. 03, 2026
Dec. 31, 2025
Current assets:
Cash and cash equivalents
$ 21,375
$ 17,161
Accounts receivable, net of provision for credit losses of $0.6 million and $0.6 million, respectively
338,729
346,079
Inventories
288,058
253,739
Contract assets
119,024
112,546
Prepaid expenses and other current assets
43,449
40,572
Total current assets
810,635
770,097
Property, plant and equipment, net
532,340
536,427
Goodwill
1,104,651
1,110,908
Other intangible assets, net
788,841
825,435
Deferred income taxes
9,014
8,994
Operating lease assets
82,574
98,437
Financing lease assets
56,429
37,109
Other long-term assets
39,113
23,170
Total assets
3,423,597
3,410,577
Current liabilities:
Accounts payable
111,850
113,130
Operating lease liabilities
8,209
9,099
Accrued expenses and other current liabilities
97,082
109,812
Total current liabilities
217,141
232,041
Long-term debt
1,237,883
1,185,179
Deferred income taxes
114,747
116,327
Operating lease liabilities
67,143
81,899
Financing lease liabilities
51,296
28,578
Other long-term liabilities
16,638
19,910
Total liabilities
1,704,848
1,663,934
Stockholders’ equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 35,481,805 and 35,481,805 shares issued, respectively; 33,992,048 and 34,346,450 shares outstanding, respectively
35
35
Additional paid-in capital
756,545
771,223
Treasury stock, at cost; 1,489,757 shares and 1,135,355 shares, respectively
(110,734)
(76,872)
Retained earnings
1,034,166
994,055
Accumulated other comprehensive income
38,737
58,202
Total stockholders’ equity
1,718,749
1,746,643
Total liabilities and stockholders’ equity
$ 3,423,597
$ 3,410,577